Definity Financial Corporation (FRA:XR6)

Intra-Cellular Therapies Statistics

Total Valuation

FRA:XR6 has a market cap or net worth of EUR 5.65 billion. The enterprise value is 5.68 billion.

Market Cap	5.65B
Enterprise Value	5.68B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	Jun 12, 2025

Share Statistics

Current Share Class	119.82M
Shares Outstanding	n/a
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	+1.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	118.45M

Valuation Ratios

The trailing PE ratio is 23.29 and the forward PE ratio is 22.08.

PE Ratio	23.29
Forward PE	22.08
PS Ratio	1.96
PB Ratio	2.26
P/TBV Ratio	4.11
P/FCF Ratio	26.71
P/OCF Ratio	21.35
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.34, with an EV/FCF ratio of 26.84.

EV / Earnings	23.41
EV / Sales	1.95
EV / EBITDA	13.34
EV / EBIT	16.45
EV / FCF	26.84

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.07.

Current Ratio	2.23
Quick Ratio	1.29
Debt / Equity	0.07
Debt / EBITDA	0.39
Debt / FCF	0.78
Interest Coverage	56.49

Financial Efficiency

Return on equity (ROE) is 11.01% and return on invested capital (ROIC) is 8.97%.

Return on Equity (ROE)	11.01%
Return on Assets (ROA)	4.40%
Return on Invested Capital (ROIC)	8.97%
Return on Capital Employed (ROCE)	6.91%
Revenue Per Employee	835,736
Profits Per Employee	70,468
Employee Count	3,442
Asset Turnover	0.59
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:XR6 has paid 88.47 million in taxes.

Income Tax	88.47M
Effective Tax Rate	26.41%

Stock Price Statistics

The stock price has increased by +50.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+50.00%
50-Day Moving Average	47.72
200-Day Moving Average	41.36
Relative Strength Index (RSI)	44.85
Average Volume (20 Days)	70

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:XR6 had revenue of EUR 2.88 billion and earned 242.55 million in profits. Earnings per share was 2.08.

Revenue	2.88B
Gross Profit	559.84M
Operating Income	342.13M
Pretax Income	335.02M
Net Income	242.55M
EBITDA	417.37M
EBIT	342.13M
Earnings Per Share (EPS)	2.08

Balance Sheet

The company has 285.32 million in cash and 165.57 million in debt, giving a net cash position of 119.75 million.

Cash & Cash Equivalents	285.32M
Total Debt	165.57M
Net Cash	119.75M
Net Cash Per Share	n/a
Equity (Book Value)	2.50B
Book Value Per Share	20.36
Working Capital	285.76M

Cash Flow

In the last 12 months, operating cash flow was 264.65 million and capital expenditures -53.13 million, giving a free cash flow of 211.52 million.

Operating Cash Flow	264.65M
Capital Expenditures	-53.13M
Free Cash Flow	211.52M
FCF Per Share	n/a

Margins

Gross margin is 19.46%, with operating and profit margins of 11.89% and 8.43%.

Gross Margin	19.46%
Operating Margin	11.89%
Pretax Margin	11.65%
Profit Margin	8.43%
EBITDA Margin	14.51%
EBIT Margin	11.89%
FCF Margin	7.35%

Dividends & Yields

This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.95%.

Dividend Per Share	0.45
Dividend Yield	0.95%
Dividend Growth (YoY)	11.74%
Years of Dividend Growth	1
Payout Ratio	20.69%
Buyback Yield	0.04%
Shareholder Yield	1.00%
Earnings Yield	4.29%
FCF Yield	3.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4